Shockwave Medical
Shockwave Medical, part of Johnson & Johnson MedTech, is a leader in the development and commercialization of innovative products that are transforming the treatment of cardiovascular disease. Its first-of-its-kind Intravascular Lithotripsy (IVL) technology has transformed the treatment of atherosclerotic cardiovascular disease by using sonic pressure waves to disrupt challenging calcified plaque, resulting in significantly improved patient outcomes. Its Reducer technology, which is under clinical investigation in the United States and is CE Marked in the European Union and the United Kingdom, is designed to provide relief to the millions of patients worldwide suffering from refractory angina by redistributing blood flow within the heart. Learn more at www.shockwavemedical.com.
Rethink Your Approach to Large Vessel Calcification: Watch Europe's First Shockwave L6 Cases
Watch the first #ShockwaveL6 cases in Europe! Brilliant work from the early users: Prof Stefano Fazzini in Rome, Dr Konstantinos Stavroulakis & Dr Michael Lichtenberg in Ansberg, Dr Michel Bosiers in Bern, Prof Raphael Coscas in Paris, and Dr Narayanan Thulasidasan & Prof Hany Zayed in London.
Hear their early experience using Shockwave L6 to treat large vessel calcium and preserve future treatment options!
Learn more about Shockwave L6 at https://shockwavemedical.com/clinicians/usa/peripheral/product-specs-resources/shockwave-l6/
US Rx only. Important Safety Information: http://bit.ly/3iEq7fC #ShockwaveIVL
